Highlighted below are the publications of the last 5 years – including those addressing SARS-CoV-2 immune response studies and the genomic analysis of drug-resistant tuberculosis. For a full list of publications, visit Adel Talaat’s authorship on PubMed.
This is an accordion element with a series of buttons that open and close related content panels.
2023
- A DNA Prime and MVA Boost Strategy Provides a Robust Immunity Against Infectious Bronchitis Virus in Chickens PMID: 36851180
-
Characterization of early immune responses elicited by live and inactivated vaccines against Johne’s disease in goats PMID: 36699320
-
Protective RNA nanovaccines against Mycobacterium avium subspecies hominissuis LINK: https://pubmed.ncbi.nlm.nih.gov/37359562/
-
The Immunogenicity and Safety of Mycobacterium tuberculosis– mosR-Based Double Deletion Strain in Mice LINK: https://pubmed.ncbi.nlm.nih.gov/37630665/
This is an accordion element with a series of buttons that open and close related content panels.
2022
- Transcriptional Profiling of Early and Late Phases of Bovine Tuberculosis PMID: 34898250
- Systemic Neutralizing Antibodies and Local Immune Responses Are Critical for the Control of SARS-CoV-2 PMID: 35746733
- Vaccine-induced systemic and mucosal T cell immunity to SARS-CoV-2 viral variants PMID: 35561224
-
Superinfection with SARS-CoV-2 Has Deleterious Effects on Mycobacterium bovis BCG Immunity and Promotes Dissemination of Mycobacterium tuberculosis PMID: 36200898
2021
- Localized and Systemic Immune Responses against SARS-CoV-2 Following Mucosal Immunization PMID: 33562141
- Genotypic analysis of nontuberculous mycobacteria isolated from raw milk and human cases in Wisconsin PMID: 33162087
- Uncovering the role of CBLB for innate immune responses regulating systemic dissemination during a Non-Tuberculous Mycobacterial infection LINK
2020
2019
- Genomic analysis of the emergence of drug-resistant strains of Mycobacterium tuberculosis in the Middle East PMID: 31882574
- Genomic Polymorphism Associated with the Emergence of Virulent Isolates of Mycobacterium bovis in the Nile Delta PMID: 31406159
- Effective mosaic-based nanovaccines against avian influenza in poultry PMID: 31300285
- The inhibitory effect of nisin on Mycobacterium avium ssp. paratuberculosis and its effect on mycobacterial cell wall PMID: 30981481
- Genomic analysis of the emergence of drug-resistant strains of Mycobacterium tuberculosis in the Middle East PMID: 30872748
2018
- Biomarkers for Early Stages of Johne’s Disease Infection and Immunization in Goats PMID: 30323794
2017
Patents
This is an accordion element with a series of buttons that open and close related content panels.
Immunogenic compositions against tuberculosis
- US10786559B2. Adel M. Talaat, Sarah K. Ward, Bassam Abomoelak. Issued (2020)
- Continuation of US20160175420A1
- US9220764B2. Adel M. Talaat, Sarah K. Ward, Bassam Abomoelak. Issued (2015)
- Continuation of US8367055B2
- US8367055B2. Adel M. Talaat, Bassam Abomoelak, Sarah K. Ward. Active (2013)
Vaccine candidates against Johne’s disease
- US20190314478A1. Adel M. Talaat. Pending (2019)
- Divisional of US20180147272A1
- US9855323B2. Adel M. Talaat. Issued (2018)
- Continuation of US9446110B2
- US9446110B2. Adel M. Talaat. Issued (2016)
- Continuation of US8758773B2
- US8758773B2. Adel M. Talaat. Issued (2014)
Global gene regulators (GGR) as vaccine candidates against paratuberculosis
- US20210246416A1. Adel M. Talaat. Pending (2021)
- Divisional of US10544389B2
- US10968425B2. Adel M. Talaat. Issued (2021)
- Divisional of US10544389B2
- US10544389B2. Adel M. Talaat. Issued (2020)
- Continuation of US9663758B2
- US9663758B2. Adel M. Talaat. Issued (2017)
Biomarkers for early diagnosis and differentiation of mycobacterial infection
- US20210190782A1. Adel M. Talaat. Pending (2021)
- Divisional of US10054586B2
- US10914739B2. Adel M. Talaat. Active (2021)
- Divisional of US10054586B2
- US20200081016A1. Adel M. Talaat, Chia-Wei Wu. Pending (2020)
- US10054586B2. Adel M. Talaat. Issued (2018)
Novel adjuvant for animal and human vaccines
- US20200390883A1. Adel M. Talaat, Shaswath Chandrasekar. Pending (2021)
Neutralizing vaccines against human coronavirus
- US20220160822A1. Adel M. Talaat, Shaswath Chandrasekar. Pending (2022)
A universal vaccine against Infectious Bronchitis Virus, Avian Influenza, Newcastle Disease Virus and Infectious Bursal Disease
- WARF: P190239US01. Adel M. Talaat and Brock Bakke. Pending
Modified Gene Vaccines Against Avian Coronavirus
- WARF: P210169. Adel M. Talaat and Sekar Chandrasekar. Pending